HomeCompareWWRL vs MRK

WWRL vs MRK: Dividend Comparison 2026

WWRL yields 21505.38% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WWRL wins by $107882141815352868864.00M in total portfolio value
10 years
WWRL
WWRL
● Live price
21505.38%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107882141815352868864.00M
Annual income
$106,904,261,402,781,760,000,000,000.00
Full WWRL calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — WWRL vs MRK

📍 WWRL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWWRLMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WWRL + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WWRL pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WWRL
Annual income on $10K today (after 15% tax)
$1,827,956.99/yr
After 10yr DRIP, annual income (after tax)
$90,868,622,192,364,500,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, WWRL beats the other by $90,868,622,192,364,500,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WWRL + MRK for your $10,000?

WWRL: 50%MRK: 50%
100% MRK50/50100% WWRL
Portfolio after 10yr
$53941070907676434432.00M
Annual income
$53,452,130,701,390,880,000,000,000.00/yr
Blended yield
99.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

WWRL
No analyst data
Altman Z
-135.5
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WWRL buys
0
MRK buys
0
No recent congressional trades found for WWRL or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWWRLMRK
Forward yield21505.38%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$107882141815352868864.00M$56.8K
Annual income after 10y$106,904,261,402,781,760,000,000,000.00$9,798.13
Total dividends collected$107817657762195783680.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WWRL vs MRK ($10,000, DRIP)

YearWWRL PortfolioWWRL Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$2,161,238$2,150,537.63$11,206$366.19+$2.15MWWRL
2$436,688,493$434,375,969.13$12,650$502.35+$436.68MWWRL
3$82,493,201,274$82,025,944,586.28$14,407$694.19+$82493.19MWWRL
4$14,569,778,490,541$14,481,510,765,177.32$16,585$967.82+$14569778.47MWWRL
5$2,405,958,319,119,619$2,390,368,656,134,740.00$19,342$1,363.89+$2405958319.10MWWRL
6$371,480,833,454,370,940$368,906,458,052,912,960.00$22,913$1,947.19+$371480833454.35MWWRL
7$53,630,466,141,085,860,000$53,232,981,649,289,680,000.00$27,662$2,823.89+$53630466141085.84MWWRL
8$7,239,827,382,966,988,000,000$7,182,442,784,196,026,000,000.00$34,159$4,173.35+$7239827382966988.00MWWRL
9$913,906,927,636,562,000,000,000$906,160,312,336,787,400,000,000.00$43,337$6,308.80+$913906927636562048.00MWWRL
10$107,882,141,815,352,870,000,000,000$106,904,261,402,781,760,000,000,000.00$56,776$9,798.13+$107882141815352868864.00MWWRL

WWRL vs MRK: Complete Analysis 2026

WWRLStock

World Wireless Communications, Inc. engages in the design and development of wired and wireless telemetry and remote control systems. Its products and services allow data from remote devices to be accessed via a secure, encrypted Internet connection using a standard Web browser in automatic meter reading and facilities management fields. The company operates through the X-traWeb products and Radio product segments. It offers X-Node, a micro-controller, which collects, processes, and transmits information to provide wired or wireless Internet access; and X-Gate product, which serves as a data collecting and transmitting system on a wired or wireless basis through the Internet to a Web and data-hosting server. The company also provides a line of 900 MHz spread spectrum radios, including the 900 SS Hopper, a frequency hopping spread spectrum radio that offers communication in various environments; and 900 SS MicroHopper that provides a smaller form-factor and lower power-consumption for short-range applications. In addition, it offers the 900 SS Direct—either as a direct sequence or frequency-hopping combined transmitter and receiver for transmitting data up to 40 kilometers, line of sight. World Wireless Communications, Inc. also manufactures and sells antennas. The company maintains approximately 80 specialty antennas for use in law enforcement, marine, and custom applications. World Wireless Communications, Inc. is based in Greenwood Village, Colorado.

Full WWRL Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this WWRL vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WWRL vs SCHDWWRL vs JEPIWWRL vs OWWRL vs KOWWRL vs MAINWWRL vs JNJWWRL vs ABBVWWRL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.